Camzyos and Drowsiness - a phase IV clinical study of FDA data
Summary:
Drowsiness is reported as a side effect among people who take Camzyos (mavacamten), especially for people who are female, 60+ old, also take Vitamin D3, and have Hypertrophic cardiomyopathy.
The phase IV clinical study analyzes which people have Drowsiness when taking Camzyos. It is created by eHealthMe based on reports of 1,625 people who have side effects when taking Camzyos from the FDA, and is updated regularly.
What is Camzyos?
Camzyos has active ingredients of mavacamten. eHealthMe is studying from 1,625 Camzyos users. Check the latest studies of Camzyos.
What is Drowsiness?
Drowsiness is found to be associated with 2,866 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.
1,625 people reported to have side effects when taking Camzyos.
Among them, 12 people (0.74%) have Drowsiness.

Among these 12 people:
What is the gender of people who have Drowsiness when taking Camzyos? *
- female: 75 %
- male: 25 %
What is the age of people who have Drowsiness when taking Camzyos? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 25 %
- 60+: 75 %
What are other drugs people take besides Camzyos? *
- Vitamin D3: 3 people, 25.00%
- Ramipril: 2 people, 16.67%
- Vitamin C: 2 people, 16.67%
- Ibuprofen: 1 person, 8.33%
- Alprazolam: 1 person, 8.33%
- Aspirin: 1 person, 8.33%
- Clopidogrel Bisulfate: 1 person, 8.33%
- Crestor: 1 person, 8.33%
- Eliquis: 1 person, 8.33%
- Gabapentin: 1 person, 8.33%
What are other side effects people have besides Drowsiness? *
- Fatigue (feeling of tiredness): 7 people, 58.33%
- Dyspnea (difficult or laboured breathing): 4 people, 33.33%
- Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 3 people, 25.00%
- Hypotension (abnormally low blood pressure): 3 people, 25.00%
- High Blood Pressure: 3 people, 25.00%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 16.67%
- Back Pain: 2 people, 16.67%
- Chest Pain: 2 people, 16.67%
- Dizziness: 2 people, 16.67%
- Drug Ineffective: 2 people, 16.67%
What are the existing conditions these people have? *
- Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 11 people, 91.67%
- Constipation: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Camzyos and have Drowsiness?
- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Camzyos:
- Camzyos (1,625 reports)
Drowsiness treatments and more:
- Drowsiness (269,040 reports)
How severe was Drowsiness and when was it recovered:
Expand to all the drugs that have ingredients of mavacamten:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Camzyos:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Drowsiness:
- Drowsiness (2,866 drugs)
Browse all the conditions that are associated with Drowsiness:
- Drowsiness (4,797 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mavacamten (the active ingredients of Camzyos) and Camzyos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Dexlansoprazole and Fluorouracil - now
- Drug interactions of Brintellix and Allegra - 11 seconds ago
- Could Cytoxan cause Depression Aggravated? - 24 seconds ago
- Could Lyrica cause Nephrogenic Systemic Fibrosis? - 39 seconds ago
- Could Libtayo cause Myocarditis? - 42 seconds ago
- Fluvastatin vs. Triglide, side effect and effectiveness comparison - 45 seconds ago
- Drug interactions of Victoza and Glutathione - 47 seconds ago
- Drug interactions of Vistaril and Haldol - 59 seconds ago
- Could Aleve cause Groin Pain? - a minute ago
- Could Cubicin cause Hearing Loss? - a minute ago